PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys

Kidney International

Volumn 71, Issue 8, 2007, Pages 764-770

  Tseng, C C ^a   Huang, J J ^a   Wang, M C ^a   Wu, A B ^a   Ko, W C ^a   Chen, W C ^a   Wu, J J ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Acute pyelonephritis; E. coli; Infection; Mice; Mutant; PapG II adhesin

Indexed keywords

ADHESIN; CYTOTOXIC NECROTIZING FACTOR 1; HEMOLYSIN; PAPG II PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BLADDER; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; FIMBRIA; GENE CONSTRUCT; GENETIC ANALYSIS; HEMAGGLUTINATION TEST; INOCULATION; KIDNEY; KIDNEY BIOPSY; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

ADHESINS, ESCHERICHIA COLI; ANIMALS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FIMBRIAE, BACTERIAL; KIDNEY; MICE; MICE, INBRED BALB C; MUTATION; PHENOTYPE; PYELONEPHRITIS; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 34247211221     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002111     Document Type: Article

References (39)

1. Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997; 11: 513-529.
2. Wiselka MJ. Bacterial and host factors in the pathogenesis of urinary tract infection. In: Cattell ER (ed). Infections of the Kidney and Urinary Tract. Oxford University Press Inc: New York, 1996, pp 8-33.
3. Sandberg T, Kaijser B, Lidin-Janson G et al. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J Clin Microbiol 1988; 26: 1471-1476.
4. Stenqvist K, Dahlen-Nilsson I, Lidin-Janson G et al. Bacteriuria in pregnancy: frequency and risk of acquisition. Am J Epidemiol 1989; 129: 372-379.
5. Hagberg L, Jodal U, Korhonen TK et al. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981; 31: 564-570.
6. Roberts JA, Marklund BI, Ilver D et al. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA 1994; 91: 11889-11893.
7. Hagberg L, Hull R, Hull S et al. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun 1983; 40: 265-272.
8. Rice JC, Peng T, Spence JS et al. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney. J Am Soc Nephrol 2005; 16: 3583-3591.
9. Mobley HL, Jarvis KG, Elwood JP et al. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: The role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol 1993; 10: 143-155.
10. Donnenberg M, Weleh R. Virulence determinats of Escherichia coli. In: Mobley H, Warren J (eds). Urinary Tract Infections. Am Soci Microbiol Press: Washington, DC, 1996, pp 135-174.
11. Snyder JA, Haugen BJ, Lockatell CV et al. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun 2005; 73: 7588-7596.
12. Lindberg F, Lund B, Johansson L et al. Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature 1987; 328: 84-87.
13. Lanne B, Olsson BM, Jovall PA et al. Glycoconjugate receptors for P-fimbriated Escherichia coli in the mouse. An animal model of urinary tract infection. J Biol Chem 1995; 270: 9017-9025.
14. O'Hanley P, Lark D, Falkow S et al. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice: Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest 1985; 75: 347-360.
15. Roberts JA, Kaack B, Kallenius G et al. Receptors for pyelonephritogenic Escherichia coli in primates. J Urol 1984; 131: 163-168.
16. Marklund BI, Tennent JM, Garcia E et al. Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol 1992; 6: 2225-2242.
17. Stromberg N, Marklund BI, Lund B et al. Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors. EMBO J 1990; 9: 2001-2010.
18. Lindstedt R, Larson G, Falk P et al. The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A. Infect Immun 1991; 59: 1086-1092.
19. Tseng CC, Wu JJ, Liu HL et al. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli. Am J Kidney Dis 2002; 39: 744-752.
20. Tseng CC, Huang JJ, Ko WC et al. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. J Urol 2001; 166: 1643-1646.
21. Wullt B, Bergsten G, Connell H et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 2000; 38: 456-464.
22. Kuehn MJ, Heuser J, Normark S et al. P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips.. Nature 1992; 356: 252-255.
23. Lund B, Lindberg F, Marklund BI et al. The PapG protein is the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 1987; 84: 5898-5902.
24. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol 1999; 2: 99-105.
25. Svanborg C, Frendeus B, Godaly G et al. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 2001; 183(Suppl 1): S61-S65.
26. Hedlund M, Duan RD, Nilsson A et al. Fimbriae, transmembrane signaling, and cell activation. J Infect Dis 2001; 183(Suppl 1): S47-S50.
27. Frendeus B, Godaly G, Hang L et al. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 2000; 192: 881-890.
28. Abraham SN, Sun D, Dale JB et al. Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature 1988; 336: 682-684.
29. Ofek I, Mirelman D, Sharon N. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 1977; 265: 623-625.
30. Miller VL, Mekalanos JJ. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc Natl Acad Sci USA 1984; 81: 3471-3475.
31. Simon R, Priefer U, Puhler A. Abroad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Biotechnology 1983; 1: 784-791.
32. Donnenberg MS, Kaper JB. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 1991; 59: 4310-4317.
33. Johnson JR, Swanson JL, Barela TJ et al. Receptor specificities of variant Gal(alpha1-4)Gal-binding PapG adhesins of uropathogenic Escherichia coli as assessed by hemagglutination phenotypes. J Infect Dis 1997; 175: 373-381.
34. Sambrook J, Fritsch EF, Mainatis T (eds). Molecular Cloning: A Laboratory Manual, 2nd edn, Cold Spring Harbor Lab: New York, 1989.
35. Lund B, Lindberg F, Normark S. Structure and antigenic properties of the tip-located P pilus proteins of uropathogenic Escherichia coli. J Bacteriol 1988; 170: 1887-1894.
36. Wang Y, Taylor DE. Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 1990; 94: 23-28.
37. Ausubel FM, Brent R, Kingston RE et al. (eds). Current Protocols in Molecular Biology. John Wiley and Sons: New Jersey, 1994.
38. Hagberg L, Engberg I, Freter R et al. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 1983; 40: 273-283.
39. Johnson JR, Brown JJ. Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection. J Infect Dis 1996; 173: 746-749.